Percutaneous debulking of large tricuspid vegetations using the AngioVac system can achieve clinical improvement but may result in abruptly worsened tricuspid regurgitation.
AngioVac may aid infection control in tricuspid endocarditis; hypothesis-generating for post-procedural TR management and larger studies.
A 27-year-old man admitted with tricuspid valve endocarditis with a large vegetation, persistent bacteremia, and pulmonary and systemic septic embolization was deemed not a suitable surgical candidate. He underwent percutaneous vegetation debulking using the AngioVac system. The patient defervesced post-operatively with clinical improvement but with abruptly worsened tricuspid regurgitation. (Level of Difficulty: Beginner.)
No takes yet. Share an insight, caveat, or question.
Mercado-Alamo et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: